Developer docs
API playgroundTry for free, no card

Search company profiles

Mathys

Full company profile

uuid000kowb

Namestring
Mathys
Websiteurl
mathysmedical.com
Company typeenum
Private
Founded yearint
1946
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBettlach, Switzerland
HQ citystring
Bettlach
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
orthopedic implants, joint replacement products, synthetic bone grafts, sports medicine devices, medical device manufacturing
Industry4 codes
1Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryYes
2Cartilage, Bone & Musculoskeletal Regeneration
CodeHLAAAGAHPrimaryNo
3Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair)
CodeHLAHAEAFPrimaryNo
4Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM)
CodeHLAHAEAGPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Implants
No data
Cost components6 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Mathys develops, produces, and distributes orthopedic medical products. Its core portfolio covers products for artificial joint replacement, synthetic bone graft substitute, and sports medicine.

Differentiator
Functional benefit
Problem solved
Product and service3 records
1Artificial joint replacement products
CategoryOrthopedic implants
2Synthetic bone graft substitute
CategoryBone graft substitutes
3Sports medicine products
CategorySports medicine devices
Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Zimmer Biomet
TypeBroad incumbent
Description

One of the largest global orthopedic device companies with deep hip and knee reconstruction portfolios directly overlapping Mathys' core joint replacement business, plus sports medicine and surgical adjacencies.

2Stryker
TypeBroad incumbent
Description

Global medical device major with a substantial orthopedics segment (hips, knees, trauma, sports medicine) directly competing with Mathys in joint reconstruction and soft-tissue repair.

3DePuy Synthes (Johnson & Johnson)
TypeBroad incumbent
Description

Johnson & Johnson's orthopedic and spinal surgery arm, competing head-on with Mathys across joint replacement, trauma, and sports medicine categories.

4Smith & Nephew
TypeBroad incumbent
Description

Global medical device company with established hip/knee reconstruction and sports medicine franchises that overlap Mathys' three product pillars.

5Enovis Corporation
TypeBroad incumbent
Description

Medical technology company with surgical and orthopedic portfolios; appears in Mathys' source data and is a likely counterpart given its surgical implant and extremity focus, making it a relevant incumbent peer.

6Exactech
TypeDirect peer
Description

US-based orthopedic implant company focused on joint replacement (hip, knee, shoulder) and bone graft substitutes, closely comparable to Mathys in product mix and mid-sized scale.

7Corin Group
TypeDirect peer
Description

UK-based orthopedic company specializing in hip and knee implants and connected technologies; similar in scale and focus to Mathys' joint reconstruction franchise.

8Waldemar Link
TypeDirect peer
Description

German-based privately held orthopedic implant manufacturer focused on hip and knee joint replacement, closely comparable to Mathys in mid-sized European specialty orthopedic positioning.

9LimaCorporate
TypeDirect peer
Description

Italian orthopedic implant company specializing in joint reconstruction, extremities, and custom implants; comparable to Mathys as a mid-sized European-focused orthopedic peer with overlapping product scope.

10Arthrex
TypeDirect peer
Description

Privately held global leader in sports medicine and arthroscopy; directly comparable to Mathys' sports medicine pillar and a benchmark for mid-sized orthopedic companies that have scaled around soft-tissue repair.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mathys

Orthopedic Implantsmathysmedical.com

Mathys firmographics

Firmographics
Name
Mathys
Website
https://mathysmedical.com
Company type
Private
Founded year
1946
Headcount range
101–250 employees
Ownership category
akta.pro rank

Mathys industry classification

Industry
Product category
Orthopedic Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
akta.pro secondary industries
Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair) (HLAHAEAF), Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

Keywords

  • Orthopedic implants
  • Joint replacement products
  • Synthetic bone grafts
  • Sports medicine devices
  • Medical device manufacturing

Where Mathys is headquartered

Location

Headquarters

HQ city
Bettlach
HQ country
Switzerland
HQ region
Europe

Markets served

Mathys business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Mathys product offering

Product offering

Core offering

Mathys develops, produces, and distributes orthopedic medical products. Its core portfolio covers products for artificial joint replacement, synthetic bone graft substitute, and sports medicine.

Differentiator

Problem solved

Functional benefit

Products and services

  • Artificial joint replacement products
  • Synthetic bone graft substitute
  • Sports medicine products

Companies that use Mathys

Customer profile

Ideal customer profiles1 record

Mathys technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Mathys partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights3 records

Mathys competitors and assessment

Company assessment

Broad incumbents

  • Zimmer Biomet: One of the largest global orthopedic device companies with deep hip and knee reconstruction portfolios directly overlapping Mathys' core joint replacement business, plus sports medicine and surgical adjacencies.
  • Stryker: Global medical device major with a substantial orthopedics segment (hips, knees, trauma, sports medicine) directly competing with Mathys in joint reconstruction and soft-tissue repair.
  • DePuy Synthes (Johnson & Johnson): Johnson & Johnson's orthopedic and spinal surgery arm, competing head-on with Mathys across joint replacement, trauma, and sports medicine categories.
  • Smith & Nephew: Global medical device company with established hip/knee reconstruction and sports medicine franchises that overlap Mathys' three product pillars.
  • Enovis Corporation: Medical technology company with surgical and orthopedic portfolios; appears in Mathys' source data and is a likely counterpart given its surgical implant and extremity focus, making it a relevant incumbent peer.

Direct peers

  • Exactech: US-based orthopedic implant company focused on joint replacement (hip, knee, shoulder) and bone graft substitutes, closely comparable to Mathys in product mix and mid-sized scale.
  • Corin Group: UK-based orthopedic company specializing in hip and knee implants and connected technologies; similar in scale and focus to Mathys' joint reconstruction franchise.
  • Waldemar Link: German-based privately held orthopedic implant manufacturer focused on hip and knee joint replacement, closely comparable to Mathys in mid-sized European specialty orthopedic positioning.
  • LimaCorporate: Italian orthopedic implant company specializing in joint reconstruction, extremities, and custom implants; comparable to Mathys as a mid-sized European-focused orthopedic peer with overlapping product scope.
  • Arthrex: Privately held global leader in sports medicine and arthroscopy; directly comparable to Mathys' sports medicine pillar and a benchmark for mid-sized orthopedic companies that have scaled around soft-tissue repair.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Mathys financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mathys leadership team

Management profile

Number of profiles

Profiles1 record

Mathys funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mathys M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mathys

What does Mathys do?

Mathys develops, produces, and distributes orthopedic medical products. Its core portfolio covers products for artificial joint replacement, synthetic bone graft substitute, and sports medicine.

When was Mathys founded?

Mathys was founded in 1946. It employs 101 to 250 people.

Where is Mathys based?

Mathys is headquartered in Bettlach, Switzerland, in the Europe region.

Who are Mathys's main competitors?

Broad incumbents on record are Zimmer Biomet, Stryker, DePuy Synthes (Johnson & Johnson), Smith & Nephew and Enovis Corporation. Direct peers are Exactech, Corin Group, Waldemar Link, LimaCorporate and Arthrex.

Does Mathys have an API?

No public API is recorded for Mathys.

What industry is Mathys in?

Mathys's product category is Orthopedic Implants. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAAAGAH, Cartilage, Bone & Musculoskeletal Regeneration. Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAnterior Cruciate Ligament (ACL) and Posterior Cruciate Ligament (PCL) Reconstruction Devices Market to Surpass US$ 19,145 Million by 2030 - Coherent Market InsightsCoherent Market Insights projects the global ACL/PCL reconstruction devices market to grow from US$10,952 million in 2022 to over US$19,145 million by 2030, representing a compound annual growth rate of 7.2%. Key market drivers include rising orthopedic disease prevalence, FDA product approvals such as Winter Innovations' EasyWhip suturing needle in May 2021, and strategic consolidation through acquisitions including Colfax Corporation's purchase of Mathys AG Bettlach and Stryker Corporation's acquisition of Wright Medical Group NV.GlobeNewswireColfax Completes Acquisition of Mathys AG BettlachColfax Corporation completed its acquisition of Mathys AG Bettlach, paying approximately $285 million in 6,544,522 shares of common stock. The deal was financed via a Section 4(a)(2) exemption from the Securities Act. Colfax plans to separate into two independent public companies by the first quarter of 2022.ColfaxcorpColfax Completes Acquisition of Mathys AG BettlachColfax Corporation has completed its acquisition of Mathys AG Bettlach for approximately $285 million, financed through the issuance of 6,544,522 shares of common stock. This transaction adds to Colfax's portfolio of orthopedic and fabrication technology products under its DJO and ESAB brands. The completion occurs as Colfax prepares for a planned separation into two independent public companies focused on specialty medical technologies and fabrication technologies.MassDeviceDJO acquires Mathys AG BettlachColfax Corp.’s DJO announced a definitive agreement to acquire Mathys AG Bettlach for an undisclosed amount. The acquisition is intended to strengthen DJO’s patient-focused innovation pipeline and broaden its reconstructive portfolio.MedicaldesignandoutsourcingDJO acquires Mathys AG BettlachColfax Corp.’s DJO announced a definitive agreement to acquire Mathys AG Bettlach for an undisclosed amount. The transaction is expected to close in the third quarter of 2021, subject to regulatory approvals, and aims to broaden DJO’s reconstructive portfolio and orthopedic leadership outside the United States.Daily Medical NewsDJO announces acquisition of Mathys AG BettlachDJO has announced the acquisition of Mathys AG Bettlach, a Switzerland-based developer of implants for artificial joint replacement. The acquisition is expected to close in the third quarter of 2021 and will enhance DJO's product portfolio with Mathys' offerings. The merger aims to strengthen both companies' positions in the orthopedic market globally.